journal
https://read.qxmd.com/read/38630490/weekly-pulsed-dye-laser-treatments-for-port-wine-birthmarks-in-infants
#1
JOURNAL ARTICLE
Shirin Bajaj, Joy Tao, David A Hashemi, Roy G Geronemus
IMPORTANCE: Early treatment of port-wine birthmark (PWB) can be life-altering and is often associated with improved outcomes and quality of life. There is growing evidence that shorter treatment intervals may play a role in more rapid PWB clearance; however, the optimal treatment interval has not been established. OBJECTIVE: To describe the outcomes of once-weekly pulsed dye laser (PDL) treatments for PWB in infants. DESIGN, SETTING, AND PARTICIPANTS: This case series analyzed the medical records of patients with PWB who received once-weekly PDL treatments between January 1, 2022, and December 31, 2023, at the Laser & Skin Surgery Center of New York...
April 17, 2024: JAMA Dermatology
https://read.qxmd.com/read/38630488/chronic-progressive-pink-yellow-papules-and-nodules-in-a-middle-aged-man
#2
JOURNAL ARTICLE
Jessica A Kern, Brian R Hinds, Veronica Shi
No abstract text is available yet for this article.
April 17, 2024: JAMA Dermatology
https://read.qxmd.com/read/38630483/laser-and-light-based-therapies-for-hirsutism-management-in-women-with-polycystic-ovarian-syndrome-a-systematic-review
#3
JOURNAL ARTICLE
Katrina Tan, Thisara Coster, Aya Mousa, Adrian Mar, Terhi Piltonen, Jacqueline A Boyle, Helena Teede, Anju Joham, Daniela Romualdi, Chau Thien Tay
IMPORTANCE: Hirsutism represents a significant concern for women with polycystic ovary syndrome (PCOS), with deleterious psychological effects warranting acknowledgment and a clear imperative to provide effective management. To our knowledge, this is the first review to exclusively examine the effectiveness of laser and light-based therapies in addressing hirsutism in women with PCOS. OBJECTIVE: To synthesize the existing literature regarding the effectiveness of laser and light hair reduction therapies, either as stand-alone treatments or in combination with systemic agents, in treating hirsutism for women with PCOS...
April 17, 2024: JAMA Dermatology
https://read.qxmd.com/read/38630467/error-in-table
#4
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
April 17, 2024: JAMA Dermatology
https://read.qxmd.com/read/38630466/potential-role-of-calcitonin-gene-related-peptide-inhibitors-in-the-treatment-of-rosacea-flushing-and-erythema
#5
JOURNAL ARTICLE
John S Barbieri
No abstract text is available yet for this article.
April 17, 2024: JAMA Dermatology
https://read.qxmd.com/read/38630457/erenumab-for-treatment-of-persistent-erythema-and-flushing-in-rosacea-a-nonrandomized-controlled-trial
#6
JOURNAL ARTICLE
Nita K F Wienholtz, Casper E Christensen, Thien P Do, Lith E W Frifelt, Josefin Snellman, Cristina L Lopez-Lopez, Alexander Egeberg, Jacob P Thyssen, Messoud Ashina
IMPORTANCE: Treatment of erythema and flushing in rosacea is challenging. Calcitonin gene-related peptide (CGRP) has been associated with the pathogenesis of rosacea, raising the possibility that inhibition of the CGRP pathway might improve certain features of the disease. OBJECTIVE: To examine the effectiveness, tolerability, and safety of erenumab, an anti-CGRP-receptor monoclonal antibody, for the treatment of rosacea-associated erythema and flushing. DESIGN, SETTING, AND PARTICIPANTS: This single-center, open-label, single-group, nonrandomized controlled trial was conducted between June 9, 2020, and May 11, 2021...
April 17, 2024: JAMA Dermatology
https://read.qxmd.com/read/38630455/hospitalization-and-continuity-of-care-in-anti-mda5-dermatomyositis
#7
JOURNAL ARTICLE
William Mark Richardson, Jill T Shah, Daniel R Mazori, Avrom S Caplan, Kristen I Lo Sicco, Alisa N Femia
No abstract text is available yet for this article.
April 17, 2024: JAMA Dermatology
https://read.qxmd.com/read/38630453/treatment-of-keratosis-lichenoides-chronica-with-upadacitinib
#8
JOURNAL ARTICLE
Jingyi Tang, Fang Liu, Wenjun Liao, Guannan Zhu
No abstract text is available yet for this article.
April 17, 2024: JAMA Dermatology
https://read.qxmd.com/read/38598233/chronic-mucocutaneous-candidiasis-due-to-stat1-gene-variant
#9
JOURNAL ARTICLE
Danrui Jing, Guanzhao Liang, Xiaofang Li
No abstract text is available yet for this article.
April 10, 2024: JAMA Dermatology
https://read.qxmd.com/read/38598229/guselkumab-for-pityriasis-rubra-pilaris-and-dysregulation-of-il-23-il-17-and-nfkb-signaling-a-nonrandomized-trial
#10
JOURNAL ARTICLE
Rose C Velasco, Connie Shao, Brett Cutler, Jennifer Strunck, Gail Kent, Pamela B Cassidy, Keith Choate, Teri M Greiling
IMPORTANCE: There is no US Food and Drug Administration-approved treatment for pityriasis rubra pilaris (PRP), and it is common for patients to fail to experience improvement with several systemic options. Involvement of interleukin (IL) 23 suggests a potential therapeutic target. OBJECTIVE: To determine whether guselkumab, an IL-23p19 inhibitor, provides clinical improvement for participants with PRP and better understand gene and protein dysregulation in PRP. DESIGN, SETTING, AND PARTICIPANTS: This single-arm, investigator-initiated nonrandomized trial was conducted from October 2019 to August 2022 at a single-center academic university with participants from 8 states in the US...
April 10, 2024: JAMA Dermatology
https://read.qxmd.com/read/38598226/oral-minoxidil-vs-topical-minoxidil-for-male-androgenetic-alopecia-a-randomized-clinical-trial
#11
JOURNAL ARTICLE
Mariana Alvares Penha, Hélio Amante Miot, Michal Kasprzak, Paulo Müller Ramos
IMPORTANCE: There has been increased interest in low-dose oral minoxidil for androgenetic alopecia (AGA) treatment. However, the efficacy of oral minoxidil for male AGA is yet to be evaluated in comparative therapeutic trials. OBJECTIVE: To compare the efficacy, safety, and tolerability of daily oral minoxidil, 5 mg, vs twice-daily topical minoxidil, 5%, for 24 weeks in the treatment of male AGA. DESIGN, SETTING, AND PARTICIPANTS: This double-blind, placebo-controlled randomized clinical trial was conducted at a single specialized clinic in Brazil...
April 10, 2024: JAMA Dermatology
https://read.qxmd.com/read/38598206/assessing-time-of-onset-for-interstitial-lung-disease-in-anti-mda5-antibody-positive-dermatomyositis
#12
JOURNAL ARTICLE
Rachel R Lin, Peyton V Warp, Andrea D Maderal, Scott A Elman
No abstract text is available yet for this article.
April 10, 2024: JAMA Dermatology
https://read.qxmd.com/read/38598197/onychomycosis
#13
JOURNAL ARTICLE
Adam I Rubin
No abstract text is available yet for this article.
April 10, 2024: JAMA Dermatology
https://read.qxmd.com/read/38598190/keratoacanthoma-and-cutaneous-squamous-cell-carcinoma-with-pd-1-and-pd-l1-inhibitor-use
#14
JOURNAL ARTICLE
Pushkar Aggarwal, Denise Clark, Aatman Shah, Kyle Rismiller, Scott A Neltner
No abstract text is available yet for this article.
April 10, 2024: JAMA Dermatology
https://read.qxmd.com/read/38568680/cutaneous-stigmata-of-bacterial-endocarditis
#15
JOURNAL ARTICLE
Matteo Castrichini, Robert J Haemmerle, Pritish K Tosh
No abstract text is available yet for this article.
April 3, 2024: JAMA Dermatology
https://read.qxmd.com/read/38568679/emergency-contraception-for-patients-taking-isotretinoin
#16
JOURNAL ARTICLE
Sarah Gold, Sarah Horvath, Andrea Zaenglein
No abstract text is available yet for this article.
April 3, 2024: JAMA Dermatology
https://read.qxmd.com/read/38568657/precision-in-language-regarding-geographic-region-of-origin-in-severe-cutaneous-adverse-drug-reaction-research
#17
JOURNAL ARTICLE
Mya L Roberson
No abstract text is available yet for this article.
April 3, 2024: JAMA Dermatology
https://read.qxmd.com/read/38568616/barriers-and-facilitators-affecting-long-term-antibiotic-prescriptions-for-acne-treatment
#18
JOURNAL ARTICLE
Ronnie A Festok, Avni S Ahuja, Jared Y Chen, Lena Chu, Jason Barron, Katherine Case, Elaine Thompson, Suephy C Chen, Jonathan Weiss, Robert A Swerlick, Cam Escoffery, Howa Yeung
IMPORTANCE: Dermatologists prescribe more oral antibiotics per clinician than clinicians in any other specialty. Despite clinical guidelines that recommend limitation of long-term oral antibiotic treatments for acne to less than 3 months, there is little evidence to guide the design and implementation of an antibiotic stewardship program in clinical practice. OBJECTIVE: To identify salient barriers and facilitators to long-term antibiotic prescriptions for acne treatment...
April 3, 2024: JAMA Dermatology
https://read.qxmd.com/read/38568614/tofacitinib-treatment-for-pretibial-myxedema
#19
JOURNAL ARTICLE
Su Wang, Xinyi Chen, Juan Bai, Qingmiao Sun, Hong Fang, Jianjun Qiao
No abstract text is available yet for this article.
April 3, 2024: JAMA Dermatology
https://read.qxmd.com/read/38568610/red-nodule-on-the-scalp-in-a-healthy-young-man
#20
JOURNAL ARTICLE
Constanza Del Puerto, Soledad Aspillaga, Alex Castro
No abstract text is available yet for this article.
April 3, 2024: JAMA Dermatology
journal
journal
44126
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.